If you require further searching capabilities for announcements please email: data@nzx.com
17 August 2023 Results of Blis Technologies Limited Annual Shareholder Meeting At Blis Technologies Limited's shareholder meeting, held in Dunedin and online today, shareholders were asked to vote on 2 resolutions, which were supported by the Board. As required by NZX Listing Rule 6.1, all voting was conducted by a poll. The resolutions passed by shareholders were: o That Dr Jorn Andreas be elected as a director of the Company. o That the Directors be authorised to fix the remuneration of the auditors for the ensuing year. Details of the total number of votes cast in person or by a proxy holder are: Resolution For Against Abstain That Dr Jorn Andreas be elected as a director of the Company. 487,987,623 99.96% 198,419 0.04% 2,288,341 That the Directors be authorised to fix the remuneration of the auditors for the ensuing year. 489,659,872 99.91% 430,301 0.09% 384,210 Ends For further information, please contact: Aimee McCammon Acting Chair +64 272 995 413 About Blis Technologies Ltd Delivering proven health benefits through evidence-based, advanced probiotics Blis Technologies is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut. Combining innovation with evidence-based research and the highest quality production controls enables the delivery of probiotic solutions for specific health targets including throat health, halitosis (bad breath), immune support, teeth and gum health and skin health. BLIS(R) products are sold throughout New Zealand and in Australia, Asia, Europe and the USA. More information about Blis Technologies Ltd can be found at www.blis.co.nz. Website: www.blis.co.nz Instagram: @blisprobiotics #blisk12 #blism18 #blisq24 Facebook: @BLISProbiotics End CA:00416538 For:BLT Type:MEETING Time:2023-08-17 11:28:48